AL5-21888-36014
2 vaccinations
16 coded responses
24 check-ins
16 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 220 / VA
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Registered in v-safe
-
2021-03-16
Dose 1 — Pfizer-BioNTech
- 2021-03-16
-
2021-03-17
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease — Feeling: Good · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-18
Survey response — days 1–6 daily, dose 1MedDRA: Blood corticotrophin decreased, Cortisol decreased, Pre-existing disease — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease — Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-21
Survey response — days 1–6 daily, dose 1MedDRA: Pre-existing disease — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Survey response — days 1–6 daily, dose 1MedDRA: Adrenal insufficiency, Pre-existing disease — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Survey response — day 7, dose 1MedDRA: Adrenocorticotropic hormone deficiency, Cushing's syndrome, Glucocorticoid deficiency, Pituitary gland operation, Pituitary-dependent Cushing's syndrome, Pre-existing disease, Secondary adrenocortical insufficiency — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Currently 25 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-30
-
2021-04-06
Dose 2 — Pfizer-BioNTech
-
2021-04-06
Survey response — day 0, dose 2MedDRA: Pre-existing disease — Feeling: Good · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Survey response — days 1–6 daily, dose 2MedDRA: Adrenal insufficiency, Adrenocorticotropic hormone deficiency, Glucocorticoid deficiency, Pituitary gland operation, Pituitary-dependent Cushing's syndrome, Pre-existing disease — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-08
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Currently 27 weeks post op for pituitary Cushing's disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease — Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Survey response — days 1–6 daily, dose 2MedDRA: Medical counselling, Pre-existing disease — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol. · Healthcare visit (other): Messaged by endocrinologist through her portal.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-13
Survey response — day 7, dose 2MedDRA: Adrenocorticotropic hormone deficiency, Cortisol decreased, Pre-existing disease — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Currently 28 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-22
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-07-06
-
2021-10-05
Survey response — 6 months, dose 2MedDRA: Hypothyroidism — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: HypothyroidismMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-07
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | |
| 2 | 2021-04-06 | Pfizer-BioNTech |
Call center
3 call center cases
3 successful
VAERS report filed, before or during a call: 3
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
Systemic reaction (other): Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
Systemic reaction (other): Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
Systemic reaction (other): Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
Systemic reaction (other): Currently 24 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
Release 6 — day 7, dose 1
Systemic reaction (other): Currently 25 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
Release 7 — day 0, dose 2
Systemic reaction (other): Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
Systemic reaction (other): Currently 27 weeks post op for pituitary Cushing's disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
Systemic reaction (other): Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
Systemic reaction (other): Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
Systemic reaction (other): Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
Systemic reaction (other): Currently 27 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
Healthcare visit (other): Messaged by endocrinologist through her portal.
Release 7 — day 7, dose 2
Systemic reaction (other): Currently 28 weeks post op for pituitary Cushings disease. In remission and secondary adrenal insufficiency. Producing zero ACTH and zero cortisol.
Release 10 — 6 months, dose 2
Symptoms: Hypothyroidism
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ✓ | ✓ | ✓ |
| SD | Hypothyroidism | · | · | ✓ |
| SRO | Adrenal insufficiency | ✓ | ✓ | ✓ |
| SRO | Adrenocorticotropic hormone deficiency | ✓ | ✓ | ✓ |
| SRO | Blood corticotrophin decreased | ✓ | ✓ | ✓ |
| SRO | Cortisol decreased | ✓ | ✓ | ✓ |
| SRO | Cushing's syndrome | ○ | ✓ | ○ |
| SRO | Glucocorticoid deficiency | ✓ | ✓ | ✓ |
| SRO | Pituitary gland operation | ✓ | ✓ | ✓ |
| SRO | Pituitary-dependent Cushing's syndrome | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Secondary adrenocortical insufficiency | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release